Paper6798568
Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells.
Ziegler HK and 1 other. Proc Natl Acad Sci U S A, 1982. Cited by 618 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Papers, record 6798568. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6798568
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ammonium Chloride | Major topic |
| Antigens, Surface | Major topic |
| Chloroquine | Major topic |
| Macrophages | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Immunity, Cellular | |
| Listeria monocytogenes | |
| Mice |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI 14732 | NIAID NIH HHS | United States | P01AI014732 | PubMed and NIH | NIH RePORTER |
| AI 17259 | NIAID NIH HHS | United States | R01AI017259 | PubMed and NIH | NIH RePORTER |
| R23AI017259 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01862042 | Palliative Care in Spinal Muscular Atrophy (SMA) 1 | Background |
Source ClinicalTrials.gov
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 109530 | Induction of cytocidal macrophages after in vitro interactions between Listeria-immune T cells and macrophages--role of H-2. | J Immunol | 1979 | https://conductscience.org/library/papers/109530 | PubMed |
| 2 | 112188 | Nature of T lymphocyte recognition of macrophage-associated antigens. II. Macrophage determination of guinea pig T cell responses to human fibrinopeptide B. | J Immunol | 1979 | https://conductscience.org/library/papers/112188 | PubMed |
| 3 | 109518 | Is genetically related macrophage factor (GRF) a soluble immune response (Ir) gene product? | J Immunol | 1979 | https://conductscience.org/library/papers/109518 | PubMed |
| 4 | 13640681 | Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs. | Immunology | 1959 | https://conductscience.org/library/papers/13640681 | PubMed |
| 5 | 28524 | Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/28524 | PubMed |
| 6 | 313419 | Nature of T lymphocyte recognition of macrophage-associated antigens. I. Response of guinea pig T cells to human fibrinopeptide B. | J Immunol | 1979 | https://conductscience.org/library/papers/313419 | PubMed |
| 7 | 4606365 | Commentary. Lysosomotropic agents. | Biochem Pharmacol | 1974 | https://conductscience.org/library/papers/4606365 | PubMed |
| 8 | 6797272 | The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. | Adv Immunol | 1981 | https://conductscience.org/library/papers/6797272 | PubMed |
| 9 | 6775227 | Regulation of the immune response--role of the macrophage. | N Engl J Med | 1980 | https://conductscience.org/library/papers/6775227 | PubMed |
| 10 | 18663840 | Cellular and humoral immunity: a distinction in antigenic recognition. | Nat New Biol | 1972 | https://conductscience.org/library/papers/18663840 | PubMed |
| 11 | 5060292 | Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. | J Exp Med | 1972 | https://conductscience.org/library/papers/5060292 | PubMed |
| 12 | 6166620 | Temporal changes of lysosome and phagosome pH during phagolysosome formation in macrophages: studies by fluorescence spectroscopy. | J Cell Biol | 1981 | https://conductscience.org/library/papers/6166620 | PubMed |
| 13 | 6795263 | Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. | J Immunol | 1981 | https://conductscience.org/library/papers/6795263 | PubMed |
| 14 | 6996569 | Control of proteolysis. | Annu Rev Biochem | 1980 | https://conductscience.org/library/papers/6996569 | PubMed |
| 15 | 6778924 | Antigen-presenting function of alveolar macrophages: uptake and presentation of Listeria monocytogenes. | J Immunol | 1981 | https://conductscience.org/library/papers/6778924 | PubMed |
| 16 | 4138630 | Immune responses against native and chemically modified albumins in mice. II. Effect of electric charge and conformation on the humoral antibody response and on helper T cell responses. | J Immunol | 1974 | https://conductscience.org/library/papers/4138630 | PubMed |
| 17 | 6766974 | Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli. | J Immunol | 1980 | https://conductscience.org/library/papers/6766974 | PubMed |
| 18 | 115958 | The specific binding of Listeria monocytogenes-immune T lymphocytes to macrophages. I. Quantitation and role of H-2 gene products. | J Exp Med | 1979 | https://conductscience.org/library/papers/115958 | PubMed |
| 19 | 6154554 | Antigen recognition by T cells and B cells: recognition of cross-reactivity between native and denatured forms of globular antigens. | Clin Immunol Immunopathol | 1980 | https://conductscience.org/library/papers/6154554 | PubMed |
| 20 | 109529 | Macrophage-T cell interactions involving Listeria monocytogenes--role of the H-2 gene complex. | J Immunol | 1979 | https://conductscience.org/library/papers/109529 | PubMed |
Cited by186
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 618 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40163479 | Severe malaria enforces short-lived effector cell differentiation but does not prevent effective secondary responses by memory CD8 T cells. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40163479 | PubMed |
| 40163355 | Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin. | Cancer Res | 2025 | https://conductscience.org/library/papers/40163355 | PubMed |
| 39698370 | Pilot Trial of Hydroxychloroquine as Add-On Therapy in Patients With Membranous Nephropathy. | Kidney Int Rep | 2024 | https://conductscience.org/library/papers/39698370 | PubMed |
| 38711668 | Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus. | Heliyon | 2024 | https://conductscience.org/library/papers/38711668 | PubMed |
| 37741812 | The effects of hydroxychloroquine and its promising use in refractory obstetric antiphospholipid syndrome. | Rheumatol Int | 2024 | https://conductscience.org/library/papers/37741812 | PubMed |
| 37171669 | Current treatment of systemic lupus erythematosus: a clinician's perspective. | Rheumatol Int | 2023 | https://conductscience.org/library/papers/37171669 | PubMed |
| 35935871 | The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35935871 | PubMed |
| 35543702 | DCs at the center of help: Origins and evolution of the three-cell-type hypothesis. | J Exp Med | 2022 | https://conductscience.org/library/papers/35543702 | PubMed |
| 35456711 | Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35456711 | PubMed |
| 34765999 | Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines. | Mol Biomed | 2020 | https://conductscience.org/library/papers/34765999 | PubMed |
| 34757864 | Bioenergetics of Islet Preparations in a Pilot Clinical Trial of Peri-Transplant Hydroxychloroquine for Autologous Islet Transplantation. | Cell Transplant | 2021 | https://conductscience.org/library/papers/34757864 | PubMed |
| 34526376 | Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic Peptides. | J Immunol | 2021 | https://conductscience.org/library/papers/34526376 | PubMed |
| 34310018 | Know thy immune self and non-self: Proteomics informs on the expanse of self and non-self, and how and where they arise. | Proteomics | 2021 | https://conductscience.org/library/papers/34310018 | PubMed |
| 34218393 | Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic. | Clin Rheumatol | 2022 | https://conductscience.org/library/papers/34218393 | PubMed |
| 34181666 | Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy. | PLoS One | 2021 | https://conductscience.org/library/papers/34181666 | PubMed |
| 33525415 | Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism. | Molecules | 2021 | https://conductscience.org/library/papers/33525415 | PubMed |
| 33377122 | Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons. | Cell Rep Med | 2020 | https://conductscience.org/library/papers/33377122 | PubMed |
| 33364965 | Hydroxychloroquine in COVID-19 Patients: Pros and Cons. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33364965 | PubMed |
| 32817221 | Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo. | J Virol | 2020 | https://conductscience.org/library/papers/32817221 | PubMed |
| 32715647 | Hydroxychloroquine in rheumatic autoimmune disorders and beyond. | EMBO Mol Med | 2020 | https://conductscience.org/library/papers/32715647 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6798568
GET https://conductscience.org/api/papers/v1/6798568/references?page=2